What pre‑operative management is recommended for a patient with antero‑septal myocardial ischemia undergoing splenectomy?

Pre-operative Management for Antero-septal Ischemia Before Splenectomy

Continue all chronic cardiac medications (especially beta-blockers and statins), optimize medical therapy, and proceed directly to surgery without routine stress testing or coronary revascularization unless the patient has unstable cardiac symptoms.

Risk Stratification

Splenectomy is classified as an intermediate-risk procedure (cardiac risk 1-5%) 1, 2. Your patient with antero-septal ischemia has at least one clinical risk factor (ischemic heart disease), placing them in a higher-risk category that requires specific perioperative management rather than additional testing 1, 3.

Key Pre-operative Actions

1. Cardiac Medication Management

Beta-blockers (Class I recommendation):

• If already on beta-blockers: Continue through surgery without interruption 1, 4
• If NOT on beta-blockers: Consider initiating at least 7 days before surgery (preferably 30 days) to allow dose titration and assessment of tolerability 1, 4
  • Start with low dose (e.g., bisoprolol 2.5-5 mg daily)
  • Titrate to target heart rate 60-70 bpm with systolic BP >100 mmHg 2, 5
  • Never start on day of surgery - this increases mortality 4

Statins (Class IIa recommendation):

• Initiate or continue statin therapy regardless of lipid levels 6, 1
• Use long-acting formulations (e.g., fluvastatin 80 mg or atorvastatin 40-80 mg daily)
• Ideally start 30 days before surgery for pleiotropic anti-inflammatory effects 5

ACE Inhibitors/ARBs:

• Continuation is reasonable perioperatively 1
• If held, restart as soon as clinically feasible postoperatively

2. Antiplatelet Therapy

Aspirin:

• Continue aspirin if patient is on it for secondary prevention of cardiovascular disease 7, 1
• For intermediate-risk surgery like splenectomy with high cardiovascular risk, continuing aspirin is reasonable (Class IIa) 7, 8
• Only discontinue 7-10 days pre-operatively if bleeding risk is prohibitively high AND cardiovascular risk is low 7, 8

P2Y12 Inhibitors (clopidogrel/ticagrelor/prasugrel):

• If patient has coronary stents: Do NOT perform elective surgery within 6 weeks of bare-metal stent or 12 months of drug-eluting stent 1, 8, 3
• If no stents and can be safely discontinued: stop clopidogrel/ticagrelor 7-10 days before surgery, prasugrel 7 days before 7, 8, 9
• Continue aspirin if possible when stopping P2Y12 inhibitor 1

3. Testing Strategy

Do NOT perform routine stress testing 1, 2, 3:

• Stress testing does not predict which patients benefit from revascularization before non-cardiac surgery 5
• Only consider stress testing if patient has unstable angina or active arrhythmia requiring immediate treatment 2, 5
• For stable ischemia with intermediate-risk surgery, proceed directly to surgery with optimized medical therapy

Baseline ECG:

• Obtain pre-operative ECG to document baseline ST-segment changes and serve as comparison for perioperative monitoring 2

4. Coronary Revascularization

Do NOT perform prophylactic revascularization (Class III recommendation) 1, 3, 10:

• Routine prophylactic coronary revascularization before non-cardiac surgery is not recommended in stable CAD 1, 10
• Revascularization does not decrease MI or death rates at 1 month or long-term 5

Only revascularize if:

• Patient has unstable angina or acute coronary syndrome requiring treatment independent of surgery 2, 10
• Patient meets standard indications for revascularization (left main disease, 3-vessel disease with reduced EF, etc.) 3, 10

Perioperative Monitoring

• Maintain normothermia (Class I) 6
• Control blood glucose if diabetic (target <150 mg/dL) 6
• Consider volatile anesthetic agents for maintenance (may have cardioprotective effects) 6
• Avoid acute beta-blocker withdrawal postoperatively 1, 4

Critical Pitfalls to Avoid

1. Do not start beta-blockers on day of surgery - associated with increased mortality 4
2. Do not use high-dose beta-blockers without titration - increases stroke risk 1, 11
3. Do not perform routine stress testing - delays surgery without improving outcomes 5
4. Do not stop chronic beta-blockers - withdrawal increases cardiac events 1
5. Do not perform surgery within 6 weeks of bare-metal stent or 12 months of drug-eluting stent if dual antiplatelet therapy must be stopped 1, 8, 3

Summary Algorithm

1. Assess cardiac stability: If unstable angina → treat first, delay surgery
2. If stable: Optimize medical therapy (beta-blockers, statins, continue aspirin)
3. Manage antiplatelet therapy: Continue aspirin; stop P2Y12 inhibitors 7-10 days pre-op if no recent stents
4. Skip stress testing unless unstable symptoms
5. Proceed to surgery with optimized medical management and perioperative monitoring

1, 2, 1, 4